Lisanti Capital Growth, LLC - CARDLYTICS INC ownership

CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 207 filers reported holding CARDLYTICS INC in Q1 2021. The put-call ratio across all filers is 1.12 and the average weighting 0.6%.

Quarter-by-quarter ownership
Lisanti Capital Growth, LLC ownership history of CARDLYTICS INC
ValueSharesWeighting
Q2 2021$3,354,000
-48.6%
26,425
-55.5%
0.42%
-50.4%
Q1 2021$6,519,000
-29.8%
59,425
-8.7%
0.84%
-35.0%
Q4 2020$9,292,000
+354.4%
65,085
+124.5%
1.29%
+239.3%
Q3 2020$2,045,000
-55.4%
28,985
-55.8%
0.38%
-59.5%
Q2 2020$4,586,000
+536.1%
65,535
+217.8%
0.94%
+292.9%
Q1 2020$721,000
-66.4%
20,620
-39.6%
0.24%
-58.2%
Q4 2019$2,145,00034,1300.57%
Other shareholders
CARDLYTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Canaan Partners VIII LLC 1,133,141$29,439,00058.62%
Polaris Venture Management Co. V, L.L.C. 2,277,342$59,165,00046.48%
CAS Investment Partners, LLC 2,162,020$56,169,00014.39%
Cannell Capital 626,975$16,289,0004.62%
Antipodean Advisors LLC 142,358$3,698,0004.50%
Shannon River Fund Management LLC 344,230$8,943,0001.42%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 19,048$495,0001.40%
Tygh Capital Management, Inc. 176,237$4,579,0000.78%
Penn Capital Management Company, LLC 263,499$6,846,0000.68%
EAM Global Investors LLC 56,866$1,477,0000.63%
View complete list of CARDLYTICS INC shareholders